Learning Objectives:

  1. To analyze historical tension between efforts to maximize drug safety and effectiveness while speeding pharmaceutical innovation.
  2. To probe role of patient advocacy organizations in modern day drug development.
  3. To assess the adequacy of methods the FDA uses in an effort to demonstrate regulatory flexibility while adhering to law and statue.
Session date: 
04/06/2022 - 12:00pm to 1:30pm CDT
P117 and Zoom
United States
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.
Speaker Name: 
G. Caleb Alexander, MD, MS